Effect of cancer and cancer treatment on human reproduction

References

• Maltaris T, Koelbl H, Seufert R, Kiesewetter et al. Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J. Androl.8(5), 515–533 (2006).
   PubMed Web of Science ®Google Scholar
• Muller J. Impact of cancer therapy on the reproductive axis. Horm. Res.59, 12–20 (2003).
   Google Scholar
• Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med. Pediatr. Oncol.33, 29–33 (1999).
   PubMedGoogle Scholar
• Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum. Reprod. Update7, 394–403 (2001).
   PubMed Web of Science ®Google Scholar
• Simon B, Lee SJ, Partridge AH, Runowicz CD. Preserving fertility after cancer. CA Cancer J. Clin.55, 211–228 (2005).
   PubMed Web of Science ®Google Scholar
• Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist11, 422–434 (2006).
   PubMed Web of Science ®Google Scholar
• Maltaris T, Boehm D, Dittrich R, Seufert R, Koelbl H. Reproduction beyond cancer: a message of hope for young women. Gynecol. Oncol.103, 1109–1121 (2006).
   PubMed Web of Science ®Google Scholar
• Stern CJ, Toledo MG, Gook DA, Seymour JF. Fertility preservation in female oncology patients. Aust. NZ J. Obstet. Gynaecol.46, 15–23 (2006).
   PubMed Web of Science ®Google Scholar
• Lee SJ, Schover LR, Partridge AH et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol.24, 2917–2931 (2006).
   PubMed Web of Science ®Google Scholar
• Kennedy S, Yudkin P, Greenall M. Cancer in pregnancy. Eur. J. Surg. Oncol.19, 405–407 (1993).
   Google Scholar
• Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am. J. Obstet. Gynecol.184, 1504–1511 (2001).
   PubMed Web of Science ®Google Scholar
• Antonelli NM, Dotters DJ, Katz VL, Kuller JA. Cancer in pregnancy – a review of the literature. Parts 1 and 2. Obstet. Gynecol. Surv.51, 125–142 (1996).
   PubMedGoogle Scholar
• Agarwal A, Allamaneni SS. Disruption of spermatogenesis by the cancer disease process. J. Natl Cancer Inst. Monogr.34, 9–12 (2005).
   Google Scholar
• Lobo RA. Potential options for preservation of fertility in women. N. Engl. J. Med.353, 64–73 (2005).
   PubMed Web of Science ®Google Scholar
• Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil. Steril.51, 651–654 (1989).
   PubMed Web of Science ®Google Scholar
• Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature428, 145–150 (2004).
   PubMed Web of Science ®Google Scholar
• Johnson M, Everitt BJ. Ovarian function. In: Essential Reproduction. Blackwell Scientific Publications, Oxford, UK, 75–100 (1988).
   Google Scholar
• Thomson AB, Critchley HO, Kelnar CJ, Wallace WH. Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. Best Pract. Res. Clin. Endocrinol. Metab.16, 311–334 (2002).
   PubMed Web of Science ®Google Scholar
• Shetty G, Meistrich ML. Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J. Natl Cancer Inst. Monogr.34, 36–39 (2005).
   Google Scholar
• Carroll PR, Whitmore WF Jr, Herr HW et al. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. J. Urol.137, 420–423 (1987).
   Google Scholar
• Meirow D, Schenker JG. Cancer and male infertility. Hum. Reprod.10, 2017–2022 (1995).
   PubMed Web of Science ®Google Scholar
• Marmor D, Elefant E, Dauchez C, Roux C. Semen analysis in Hodgkin’s disease before the onset of treatment. Cancer57, 1986–1987 (1986).
   PubMed Web of Science ®Google Scholar
• Redman JR, Bajorunas DR, Goldstein MC et al. Semen cryopreservation and artificial insemination for Hodgkin’s disease. J. Clin. Oncol.5, 233–238 (1987).
   PubMed Web of Science ®Google Scholar
• Barr RD, Clark DA, Booth JD. Dyspermia in men with localized Hodgkin’s disease. A potentially reversible, immune-mediated disorder. Med. Hypotheses40, 165–168 (1993).
   PubMed Web of Science ®Google Scholar
• Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common development disorder with environmental aspects. Hum. Reprod.16, 972–978 (2001).
   PubMed Web of Science ®Google Scholar
• Minton SE, Munster PN. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control9, 466–472 (2002).
   PubMedGoogle Scholar
• Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum. Reprod. Update7, 535–543 (2001).
   PubMed Web of Science ®Google Scholar
• Behringer K, Breuer K, Reineke T et al. Secondary amenorrhea after Hodgkin lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin Lymphoma Study Group. J. Clin. Oncol.23, 7555–7564 (2005).
   PubMed Web of Science ®Google Scholar
• Katoh MA, Cain KT, Hughes LA, Foxworth LB, Bishop JB, Generoso WM. Female-specific dominant lethal effects in mice. Mutat. Res.230, 205–217 (1990).
   PubMed Web of Science ®Google Scholar
• Lushbaugh CC, Casarett GW. The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer37(Suppl. 2), 1111–1125 (1976).
   PubMed Web of Science ®Google Scholar
• Wallace WH, Shalet SM, Hendry JH, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br. J. Radiol.62, 995–998 (1989).
   PubMed Web of Science ®Google Scholar
• Chiarelli AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964–1988 in Ontario, Canada. Am. J. Epidemiol.150, 245–254 (1999).
   PubMed Web of Science ®Google Scholar
• Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J. Natl Cancer Inst. Monogr.34, 64–68 (2005).
   Google Scholar
• Wallace WH, Thomson AB. Preservation of fertility in children treated for cancer. Arch. Dis. Child.88, 493–496 (2003).
   PubMed Web of Science ®Google Scholar
• Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int. J. Cancer43, 399–402 (1989).
   PubMed Web of Science ®Google Scholar
• Nomura T. Transgenerational effects of radiation and chemicals in mice and humans. J. Radiat. Res. (Tokyo)47(Suppl. B), 83–97 (2006).
   Google Scholar
• Swerdlow AJ, Jacobs PA, Marks A et al. Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin’s disease: an investigation including chromosome examinations. Br. J. Cancer74, 291–296 (1996).
   PubMed Web of Science ®Google Scholar
• Sankila R, Olsen JH, Anderson H et al. Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N. Engl. J. Med.338, 1339–1344 (1998).
   PubMed Web of Science ®Google Scholar
• Apperley JF, Reddy N. Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev.9, 93–116 (1995).
   PubMed Web of Science ®Google Scholar
• Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum. Reprod. Update11, 69–89 (2005).
   Google Scholar
• Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J. Clin. Endocrinol. Metab.78, 1282–1286 (1994).
   PubMedGoogle Scholar
• Constine LS, Woolf PD, Cann D et al. Hypothalamic–pituitary dysfunction after radiation for brain tumors. N. Engl. J. Med.328, 87–94 (1993).
   PubMed Web of Science ®Google Scholar
• Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum. Reprod. Update7, 394–403 (2001).
   PubMed Web of Science ®Google Scholar
• Sorosky JI, Scott-Conner CE. Breast disease complicating pregnancy. Obstet. Gynecol. Clin. North Am.25, 353–363 (1998).
   Google Scholar
• Gwyn K. Children exposed to chemotherapy in utero. J. Natl Cancer Inst. Monogr.34, 69–71 (2005).
   PubMedGoogle Scholar
• Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol.5, 283–291 (2004).
   PubMed Web of Science ®Google Scholar
• Benjamin EM. Chemically Induced Birth Defects (2nd Edition). Schardein JL (Ed.). Marcel Dekker, NY, USA (1993).
   Google Scholar
• Buekers TE, Lallas TA. Chemotherapy in pregnancy. Obstet. Gynecol. Clin. North Am.25, 323–329 (1998).
   PubMed Web of Science ®Google Scholar
• Aviles A, Diaz-Maqueo JC, Talavera A et al. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am. J. Hematol.36, 243–248 (1991).
   PubMed Web of Science ®Google Scholar
• Zemlickis D, Lishner M, Degendorfer P et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med.152, 573–576 (1992).
   PubMed Web of Science ®Google Scholar
• Garber J. Long-term follow-up of children exposed in utero to antineoplastic agents. Semin. Oncol.16, 437–444 (1989).
   Web of Science ®Google Scholar
• Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin. Oncol.16, 388–396 (1989).
   PubMed Web of Science ®Google Scholar
• Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch. Intern. Med.148, 2058–2064 (1988).
   PubMed Web of Science ®Google Scholar
• Doll RC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin. Oncol.16, 337–346 (1989).
   PubMed Web of Science ®Google Scholar
• Germann N, Goffinet F, Goldwassser F. Anthracyclines during pregnancy: embryo–fetal outcome in 160 patients. Ann. Oncol.15, 146–150 (2004).
   PubMed Web of Science ®Google Scholar
• Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk. Lymphoma33, 65–76 (1999).
   PubMed Web of Science ®Google Scholar
• Meirow D, Schiff E. Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data. J. Natl Cancer Inst. Monogr.34, 21–25 (2005).
   Google Scholar
• Fenig E, Mishaeli M, Kalish Y, Lishner M. Pregnancy and radiation. Cancer Treat. Rev.27, 1–7 (2001).
   Web of Science ®Google Scholar
• Puscheck E, Philip PA, Jeyendran RS. Male fertility preservation and cancer treatment. Cancer Treat. Rev.30, 173–180 (2004).
   PubMed Web of Science ®Google Scholar
• Brougham MF, Kelnar CJ, Sharpe RM, Wallace HB. Male fertility following childhood cancer: current concepts and future therapies. Asian J. Androl.5, 325–337 (2003).
   PubMedGoogle Scholar
• Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin. Oncol. (R. Coll. Radiol.)1, 75–79 (1989).
   Google Scholar
• Shalet SM, Didi M, Ogilvy-Stuart AL, Schulga J, Donaldson MD. Growth and endocrine function after bone marrow transplantation. Clin. Endocrinol. (Oxf.)42, 333–339 (1995).
   Google Scholar
• Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J. Androl.15, 608–613 (1994).
   PubMed Web of Science ®Google Scholar
• Gordon W Jr, Siegmund K, Stanisic TH et al. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy (SWOG-8711). Southwest Oncology Group. Int. J. Radiat. Oncol. Biol. Phys.38, 83–94 (1997).
   Google Scholar
• Socie G, Salooja N, Cohen A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood101, 3373–3385 (2003).
   PubMed Web of Science ®Google Scholar
• Martin RH, Hildebrand K, Yamamoto J et al. An increased frequency of human sperm chromosomal abnormalities after radiotherapy. Mutat. Res.174, 219–225 (1986).
   PubMedGoogle Scholar
• Fattibene P, Mazzei F, Nuccetelli C, Risica S. Prenatal exposure to ionizing radiation: sources, effects and regulatory aspects. Acta Paediatr.88, 693–702 (1999).
   PubMed Web of Science ®Google Scholar
• Siimes MA, Rautonen J. Small testicles with impaired production of sperm in adult male survivors of childhood malignancies. Cancer65, 1303–1306 (1990).
   Google Scholar
• Boekelheide K, Schoenfeld HA, Hall SJ et al. Gonadotropin-releasing hormone antagonist (Cetrorelix) therapy fails to protect nonhuman primates (Macaca arctoides) from radiation-induced spermatogenic failure. J. Androl.26, 222–234 (2005).
   Google Scholar
• Wallace EM, Groome NP, Riley SC, Parker AC, Wu FC. Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. J. Clin. Endocrinol. Metab.82, 3111–3115 (1997).
   PubMed Web of Science ®Google Scholar
• van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, Velde ER. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil. Steril.79, 482–488 (2003).
   PubMed Web of Science ®Google Scholar
• Burger HG, Dudley EC, Hopper JL et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J. Clin. Endocrinol. Metab.80, 3537–3545 (1995).
   PubMed Web of Science ®Google Scholar
• Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil. Steril.64, 991–994 (1995).
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum. Reprod.3, 851–855 (1988).
   PubMed Web of Science ®Google Scholar
• Muttukrishna S, Knight PG. Inverse effects of activin and inhibin on the synthesis and secretion of FSH and LH by ovine pituitary cells in vitro.J. Mol. Endocrinol.6, 171–178 (1991).
   Google Scholar
• Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J. Clin. Endocrinol. Metab.81, 2742–2745 (1996).
   PubMed Web of Science ®Google Scholar
• Munz W, Hammadeh ME, Seufert R, Schaffrath M, Schmidt W, Pollow K. Serum inhibin A, inhibin B, pro-α C, and activin A levels in women with idiopathic premature ovarian failure. Fertil. Steril.82, 760–762 (2004).
   Google Scholar
• Seifer DB, Scott RT Jr, Bergh PA et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil. Steril.72, 63–65 (1999).
   PubMed Web of Science ®Google Scholar
• van Rooij IA, Broekmans FJ, Velde ER et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum. Reprod.17, 3065–3071 (2002).
   PubMed Web of Science ®Google Scholar
• Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction131, 1–9 (2006).
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction124, 601–609 (2002).
   PubMed Web of Science ®Google Scholar
• Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet2, 645–647 (1987).
   PubMed Web of Science ®Google Scholar
• Hendriks DJ, Broekmans FJ, Bancsi LF, de Jong FH, Looman CW, Te Velde ER. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Hum. Reprod.20, 163–169 (2005).
   Google Scholar
• Sharara FI, Scott RT Jr, Seifer DB. The detection of diminished ovarian reserve in infertile women. Am. J. Obstet. Gynecol.179, 804–812 (1998).
   PubMed Web of Science ®Google Scholar
• Padilla SL, Bayati J, Garcia JE. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil. Steril.53, 288–294 (1990).
   PubMed Web of Science ®Google Scholar
• Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ. The gonadotropin-releasing hormone agonist stimulation test – a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil. Steril.56, 711–717 (1991).
   PubMed Web of Science ®Google Scholar
• Fabregues F, Balasch J, Creus M et al. Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome. J. Assist. Reprod. Genet.17, 13–19 (2000).
   Google Scholar
• Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil. Steril.69, 505–510 (1998).
   PubMed Web of Science ®Google Scholar
• Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, Te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum. Reprod.20, 611–615 (2005).
   PubMed Web of Science ®Google Scholar
• Wallace WH, Kelsey TW. Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum. Reprod.19, 1612–1617 (2004).
   PubMed Web of Science ®Google Scholar
• Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil. Steril.77, 328–336 (2002).
   PubMed Web of Science ®Google Scholar